Work

Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia

Year: 2005

Type: article

Source: Experimental Hematology

DOI: 10.1016/j.exphem.2004.12.001

Authors: W. Nicholas Haining, Angelo A. Cardoso, Heather L. Keczkemethy, Mark Fleming, Donna Neuberg, Daniel J. DeAngelo, Richard M. Stone, Ilene Galinsky, Lewis B. Silverman, Stephen E. Sallan, Lee M. Nadler, Eva C. Guinan

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Boston Children's Hospital

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1296528778, G1609452217, Tumor Antigen Discovery in ALL by Expression Profiling, Therapeutic Index of Acute Lymphoblastic Leukemia

OpenAlex ID: W2092278351

FWCI: 1.073

Cites: 50

Cited by: 29

Related to: 10